Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China

References

• Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017;9(1):e1361574. doi:10.1080/19381980.2017.1361574
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the national rosacea society expert committee. J Am Acad Dermatol. 2018;78(1):148–155. doi:10.1016/j.jaad.2017.08.037
   PubMed Web of Science ®Google Scholar
• Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47(5):497–502. doi:10.1111/1346-8138.15301
   PubMed Web of Science ®Google Scholar
• Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282–289.
   PubMed Web of Science ®Google Scholar
• Huang YX, Li J, Zhao ZX, et al. Effects of skin care habits on the development of rosacea: a multi-center retrospective case-control survey in Chinese population. PLoS One. 2020;15(4):e0231078. doi:10.1371/journal.pone.0231078
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Anderson R, Cook-Bolden F, et al. Standard management options for rosacea: the 2019 update by the national rosacea society expert committee. J Am Acad Dermatol. 2020;82(6):1501–1510. doi:10.1016/j.jaad.2020.01.077
   PubMed Web of Science ®Google Scholar
• Chen Q, Tang Y, Shi X, et al. Prevalence, clinical characteristics, and health-related quality of life of rosacea in Chinese adolescents: a population-based study. J Eur Acad Dermatol Venereol. 2020. doi:10.1111/jdv.16576
   Web of Science ®Google Scholar
• Wang Z, Xie H, Gong Y, et al. Relationship between rosacea and sleep. J Dermatol. 2020;47(6):592–600. doi:10.1111/1346-8138.15339
   PubMed Web of Science ®Google Scholar
• Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol. 2014;71(4):760–763. doi:10.1016/j.jaad.2014.05.044
   PubMed Web of Science ®Google Scholar
• Tan J, Steinhoff M, Bewley A, et al. Rosacea: beyond the visible. The BMJ hosted content; 2018. Available from: https://hosted.bmj.com/rosaceabeyondthevisible. Accessed May, 2019.
   Google Scholar
• Rone M, Kisis J. A12 IPL therapy in the inflammatory stage of rosacea. J Cosmet Dermatol. 2002;1(2):108. doi:10.1046/j.1473-2165.2002.00040_13.x
   Google Scholar
• Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol. 2008;159(3):628–632.
   PubMed Web of Science ®Google Scholar
• Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg. 2007;33(4):449–454.
   PubMed Web of Science ®Google Scholar
• Li YH, Wu Y, Chen JZ, et al. A split-face study of intense pulsed light on photoaging skin in Chinese population. Lasers Surg Med. 2010;42(2):185–191. doi:10.1002/lsm.20889
   PubMed Web of Science ®Google Scholar
• Hofmann MA, Lehmann P. Physical modalities for the treatment of rosacea. J Dtsch Dermatol Ges. 2016;14(Suppl 6):38–43.
   Google Scholar
• VanBeek MJ. Integrating patient preferences with health utilities - a variation on health-related quality of life. Arch Dermatol. 2008;144(8):1037–1041. doi:10.1001/archderm.144.8.1037
   Google Scholar
• Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ. 2001;10(1):39–52. doi:10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Samson AL, Schokkaert E, Thébaut C, et al. Fairness in cost-benefit analysis: a methodology for health technology assessment. Health Econ. 2018;27(1):102–114.
   PubMed Web of Science ®Google Scholar
• Haefeli M, Elfering A, McIntosh E, Gray A, Sukthankar A, Boos N. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery. Value Health. 2008;11(4):575–588. doi:10.1111/j.1524-4733.2007.00282.x
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907–912. doi:10.1016/j.jaad.2004.01.048
   PubMed Web of Science ®Google Scholar
• Sadick M, Muller-Wille R, Wildgruber M, Wohlgemuth WA. Vascular anomalies (part i): classification and diagnostics of vascular anomalies. Rofo. 2018;190(9):825–835. doi:10.1055/a-0620-8925
   Google Scholar
• Xiao Y, Chen L, Jing D, et al. Willingness-to-pay and benefit-cost analysis of chemical peels for acne treatment in China. Patient Prefer Adherence. 2019;13:363–370. doi:10.2147/PPA.S194615
   PubMed Web of Science ®Google Scholar
• Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The dermatology life quality index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997–1035.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology life quality index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. The 2019 Yearbook of Health Statistics of China. Beijing: Beijing Union Medical University Press; 2019.
   Google Scholar
• National Bureau of Statistical of the People’s Republic of China. China Labour Statistical Yearbook 2019. Beijing: China Statistics Press; 2019.
   Google Scholar
• Trippoli S. Incremental cost-effectiveness ratio and net monetary benefit: current use in pharmacoeconomics and future perspectives. Eur J Intern Med. 2017;43:e36. doi:10.1016/j.ejim.2017.05.015
   PubMed Web of Science ®Google Scholar
• Firth SJ. The quality adjusted life year: a total-utility perspective. Camb Q Healthc Ethics. 2018;27(2):284–294. doi:10.1017/S0963180117000615
   Web of Science ®Google Scholar
• Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol. 1999;141(6):1067–1075. doi:10.1046/j.1365-2133.1999.03207.x
   Web of Science ®Google Scholar
• Schiffner R, Brunnberg S, Hohenleutner U, Stolz W, Landthaler M. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol. 2002;146(3):440–447. doi:10.1046/j.1365-2133.2002.04613.x
   PubMed Web of Science ®Google Scholar
• Delfino M Jr, Holt EW, Taylor CR, Wittenberg E, Qureshi AA. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study. J Am Acad Dermatol. 2008;59(3):439–447. doi:10.1016/j.jaad.2008.05.032
   Web of Science ®Google Scholar
• Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306(3):279–286. doi:10.1007/s00403-013-1402-1
   PubMed Web of Science ®Google Scholar
• Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol. 2013;27(6):734–738. doi:10.1111/j.1468-3083.2012.04549.x
   PubMed Web of Science ®Google Scholar
• Liu SW, Tkachenko E, Lam C, et al. Willingness-to-pay stated preferences in cutaneous lupus erythematosus: a pilot study. Arch Dermatol Res. 2019.
   Web of Science ®Google Scholar
• Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC. Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience. J Am Acad Dermatol. 2019;80(6):1722–1729.e1727. doi:10.1016/j.jaad.2018.08.049
   PubMed Web of Science ®Google Scholar
• Seidler AM, Bayoumi AM, Goldstein MK, Cruz PD Jr, Chen SC. Willingness to pay in dermatology: assessment of the burden of skin diseases. J Invest Dermatol. 2012;132(7):1785–1790. doi:10.1038/jid.2012.50
   PubMed Web of Science ®Google Scholar
• Stefanidou M, Evangelou G, Kontodimopoulos N, et al. Willingness to pay and quality of life in patients with pruritic skin disorders. Arch Dermatol Res. 2019;311(3):221–230. doi:10.1007/s00403-019-01900-5
   PubMed Web of Science ®Google Scholar